5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.21▼ | 1.22▼ | 1.22▼ | 1.17▲ | 1.11▲ |
MA10 | 1.23▼ | 1.23▼ | 1.20▼ | 1.16▲ | 1.26▼ |
MA20 | 1.22▼ | 1.19▼ | 1.18▲ | 1.13▲ | 1.20▼ |
MA50 | 1.21▼ | 1.16▲ | 1.14▲ | 1.28▼ | 0.92▲ |
MA100 | 1.18▲ | 1.15▲ | 1.15▲ | 1.17▲ | 1.27▼ |
MA200 | 1.15▲ | 1.13▲ | 1.15▲ | 0.91▲ | 2.97▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | 0.000▼ | 0.004▲ | 0.018▲ | -0.033▼ |
RSI | 43.575▼ | 49.494▼ | 53.870▲ | 50.875▲ | 52.423▲ |
STOCH | 13.535▼ | 48.519 | 67.720 | 61.392 | 20.656 |
WILL %R | -100.000▼ | -71.429 | -62.500 | -37.037 | -73.011 |
CCI | -108.644▼ | -40.191 | 27.798 | 114.389▲ | -47.921 |
Thursday, May 16, 2024 05:18 AM
Q1 2024 Earnings Call Transcript May 15, 2024 Operator: Good morning, ladies and gentlemen, and welcome to the Adaptimmune Q1 2024 Financial and Business Update Conference Call. I would now like to ...
|
Thursday, May 16, 2024 02:06 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
|
Wednesday, May 15, 2024 10:05 AM
Adaptimmune Therapeutics (NASDAQ:ADAP) just reported results for the first quarter of 2024.Adaptimmune Therapeutics reported earnings per share of -18 cents. This was below the analyst estimate for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 1.29 | 1.29 | 1.19 | 1.19 | 463,270 |
15/05/24 | 1.19 | 1.27 | 1.13 | 1.24 | 1,418,381 |
14/05/24 | 1.17 | 1.23 | 1.12 | 1.15 | 533,333 |
13/05/24 | 1.17 | 1.19 | 1.14 | 1.17 | 428,526 |
10/05/24 | 1.13 | 1.21 | 1.08 | 1.12 | 529,219 |
09/05/24 | 1.15 | 1.22 | 1.12 | 1.14 | 993,489 |
08/05/24 | 1.09 | 1.14 | 1.02 | 1.14 | 974,866 |
07/05/24 | 1.15 | 1.15 | 1.06 | 1.10 | 1,035,003 |
06/05/24 | 1.23 | 1.23 | 1.11 | 1.15 | 842,132 |
03/05/24 | 1.22 | 1.24 | 1.17 | 1.19 | 850,665 |
|
|
||||
|
|
||||
|
|